Focused-ultrasound developer InSightec has received Health Canada approval for its ExAblate system.
The third-generation version of ExAblate was approved for MR-guided focused ultrasound treatment of uterine fibroids and for pain palliation of bone metastases, according to the firm. It's now available for Canadian patients.